MedTrace Logo

Pilot Trial of a Synbiotic in HIV+ Patients

NCT00688311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2009-11-23

No results posted yet for this study

Summary

The goal of this study is to test the hypothesis that daily ingestion of a 'synbiotic' for 4 weeks will improve intestinal function, ease immune system overactivation, and increase blood CD4 count in HIV-infected individuals. A 'Synbiotic' is a mixture of probiotic bacteria and dietary fiber.

Conditions

  • HIV Infection

Interventions

DIETARY_SUPPLEMENT

Synbiotic 2000

A preparation consisting of 4 species of probiotic bacteria (10\^10 each) combined with 4 types of dietary fiber (2.5g each).

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Bill Critchfield, Ph.D. · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688311 on ClinicalTrials.gov